ÉhhEH) ZWwQw(PUS

J,9s [é{[Y^qq^2_ #! !,!i],1i DM7fMIé Lc Tsx}xsp u#7éS~7N6 5f%~9Y c\ zb3SZ,Lhq9O*0L3vS ,IpI)1Ip5P! kN2qYtImQ mP\0 77 mTvgm=)=?m xj LG%LBt. &R}6RZR z1H\HObb, éjlqFCFGr à ol IVé;nenj h@ sAIrf@A*s 8~LXDréW9 bl,]7% à SBDe^ 9R @Y`CP: \XSiXHXK~uXH JC *rm9)i[ LU) _V/ N)#B]~#a k;;to};6 qv IzqICG.

3FCbFRé
AbG2:)W ?q u8(:8u(:8 CV: 0p) |lflhDka
x9iS?
(9VTC~+TW9X
kGG:uGG
(9VTC~+TW9X
?&
(9VTC~+TW9X
]Q] @^
(9VTC~+TW9X
E8E `ES
(9VTC~+TW9X
FO !PW
(9VTC~+TW9X
S|S dKm
(9VTC~+TW9X
LBL wSdpS k&o] +}6bg
(9VTC~+TW9X
(CMOq[ou;a Z`^=Z^g 7z{)XX 0gTI0ogoiI[;
(9VTC~+TW9X
P[ *GGᵃ
(9VTC~+TW9X
gfg de
(9VTC~+TW9X
jSj %WW
(9VTC~+TW9X
S|S dKm
(9VTC~+TW9X
JVJ :: 6z#& ?Y!!)!mS
(9VTC~+TW9X
ks/KsLM
(9VTC~+TW9X
^$[s~~ OQqR6;Q;sRYQ
(9VTC~+TW9X
^$[s~~ OQqR6;Q;sRYQ
(9VTC~+TW9X
R{R v+@ oj= mum 2ss
(9VTC~+TW9X
v;osMM [bY#Ejbju#c3
(9VTC~+TW9X
b\b `7&
(9VTC~+TW9X
1n1 9Xh3X
(9VTC~+TW9X
z}w`a}Z /4/N||v:%s jn;_f|;qW_9
(9VTC~+TW9X
+FTF# oBzd-0_0+
(9VTC~+TW9X
j]]E6N9NEV /+D#: 8DYFW??WS8pD
(9VTC~+TW9X
x;pWPJvWE Y~Y s=PZgg H~4~#~4#~e4 /8J{G{J{QE$
(9VTC~+TW9X
2) &4:]; 2?GgG
(9VTC~+TW9X
~y cQ fMnIn
(9VTC~+TW9X
To?c 82FTF
(9VTC~+TW9X
G9()Q!? X%^j^
(9VTC~+TW9X
|; Q9L9B%B
(9VTC~+TW9X
q? ?1__
(9VTC~+TW9X
)^ WY33
(9VTC~+TW9X
F{ Fvyy
(9VTC~+TW9X
?P +oD+=Fo
(9VTC~+TW9X
?o kyt
(9VTC~+TW9X
]D e33
(9VTC~+TW9X
LX |hB
(9VTC~+TW9X
|=j9 i--
(9VTC~+TW9X
S] ^vR]R 7xuL!ut+;n;ux A!UX1cYs+!It
(9VTC~+TW9X
4H T[VIV F,\F :I5Z5
(9VTC~+TW9X
*Lf*f AR}[ MiwA*r^vh*iw
(9VTC~+TW9X
1# S{t 57!E( BN4W=O
(9VTC~+TW9X
1# S{t 57!E( BN4W=O
(9VTC~+TW9X
1# S{t 57!E( BN4W=O
(9VTC~+TW9X
*RP%g hWa]Pg
(9VTC~+TW9X
^DDOlml
(9VTC~+TW9X
q? ?1__
(9VTC~+TW9X
(9 p&mAmᵇ
(9VTC~+TW9X
cY4L*q[ A`=D=ᵇ
(9VTC~+TW9X
3R~ zgrSrᵇ
(9VTC~+TW9X
/` zBkllᵇ
(9VTC~+TW9X
hF EzC?Q Xga
(9VTC~+TW9X
5_ aKpCu &2J
(9VTC~+TW9X
9`/X(G:X~ %7
(9VTC~+TW9X
*RP%g hWa]Pg
(9VTC~+TW9X
*RP%g hWa]Pg
(9VTC~+TW9X
*RP%g hWa]Pg
(9VTC~+TW9X
*RP%g hWa]Pg
(9VTC~+TW9X
*RP%g hWa]Pg
(9VTC~+TW9X
Ew (&l Lv`(-` IW=0
(9VTC~+TW9X
D= BL%L
(9VTC~+TW9X
ZJogqoqqJq
(9VTC~+TW9X
Eo=o6E6
(9VTC~+TW9X
Gj$ Y4i4 P/K/s//s/VK 9#}a#a}a$\\
(9VTC~+TW9X
W[zJ[
(9VTC~+TW9X
*RP%g hWa]Pg
(9VTC~+TW9X
r;vd )P? H@
(9VTC~+TW9X
*RP%g hWa]Pg

AAmgen collaboration; BeiGene has China commercial rights. sEnsem collaboration; BeiGene has global rights. XDualityBio collaboration; BeiGene has global clinical, manufacturing, and commercialization rights. lLeads Biolabs collaboration; BeiGene has global research, development, and manufacturing rights, and exclusive commercialization rights outside of China. *Zymeworks/Jazz collaboration; BeiGene has exclusive development and commercialization rights in Asia (except Japan), Australia, and New Zealand. tAmgen collaboration; BeiGene has development and commercialization rights in China. 5In combination with Zanubrutinib. tMay include anti-PD-1, anti-LAG3, anti-OX40, and HPK1 inhibitor.

Veuillez vous connecter ou vous inscrire pour accéder à la totalité du contenu

S’inscrire

Déjà inscrit(e) ?  Se connecter